When chronic myringitis presents in the setting of acute otitis media, standard first-line antibiotic choices may not be appropriate for every patient. In those with a documented penicillin allergy, the treatment pathway shifts substantially — selecting an agent that provides adequate coverage while avoiding the allergen.
This protocol applies when acute otitis media is present alongside chronic myringitis and the patient has a penicillin allergy. The allergy status is the key clinical modifier: it excludes the most commonly used antibiotic class and requires a structured alternative approach.
The approach combines adequate analgesia with antibiotic coverage drawn from an alternative drug class appropriate for penicillin-allergic patients. The specific agents, dosing parameters, and selection criteria across available options are laid out in the full structured protocol.
Clinical goal: resolution of ear pain and fever, assessed at 48–72 hours after initiation of treatment.